C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2011
12/01/2011	WO2011149492A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
12/01/2011	WO2011148962A1 Novel heterocyclic compound or salt thereof
12/01/2011	WO2011148956A1 Fused imidazole derivative
12/01/2011	WO2011147810A1 THE USE OF sGC STIMULATORS, sGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS (SSc).
12/01/2011	WO2011147809A1 Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
12/01/2011	WO2011147326A1 Phenanthroindolizidine alkaloid organic acid salt derivatives and medicinal use thereof
12/01/2011	WO2011079296A3 Photoconductive sensor materials for detection of explosive vapor
12/01/2011	US20110294837 Aurora Kinase Modulators and Methods of Use
12/01/2011	US20110294819 Hepatitis C Virus Inhibitors
12/01/2011	US20110294807 Compounds for the prevention and treatment of cardiovascular disease
12/01/2011	US20110294806 Azaindole derivatives as kinase inhibitors
12/01/2011	US20110294805 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators and methods of use thereof
12/01/2011	US20110294804 Novel bicyclic heterocyclic compound
12/01/2011	US20110294799 Organic Compounds
12/01/2011	US20110294792 Purine derivatives as kinase inhibitors
12/01/2011	US20110294791 Pirenzepine as an agent in cancer treatment
12/01/2011	US20110294790 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
12/01/2011	US20110294786 Substituted bicyclic pyrimidone derivatives
12/01/2011	US20110294779 Novel imidazopyridines
12/01/2011	US20110294777 Beta-lactamase inhibitors
12/01/2011	US20110294756 Gamma secretase modulators
12/01/2011	US20110294749 Diaminopyrimidinecarboxamide derivative
12/01/2011	US20110294229 Colorimetric and fluorimetric fluoride sensing
12/01/2011	US20110293889 Novel and improved processes for the preparation of paliperidone
12/01/2011	DE102010021637A1 Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung Substituted 5-fluoro-1H-pyrazolopyridines, and their use
12/01/2011	CA2804304A1 Heterocyclic compounds and uses thereof
12/01/2011	CA2800709A1 The use of sgc stimulators, sgc activators, alone and combinations with pde5 inhibitors for the treatment of systemic sclerosis (ssc)
12/01/2011	CA2800697A1 Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
12/01/2011	CA2800618A1 Heteroaryl compounds and methods of use thereof
12/01/2011	CA2800530A1 Inhibitors of hcv ns5a
12/01/2011	CA2800521A1 Fused imidazole derivative
12/01/2011	CA2800509A1 Inhibitors of hcv ns5a
12/01/2011	CA2800176A1 Bicyclic heteroaryl kinase inhibitors and methods of use
12/01/2011	CA2799280A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/2011
11/30/2011	EP2390253A1 Morylenes, a new class of modified rylenes
11/30/2011	EP2389381A1 Spiroindolinone derivative prodrugs
11/30/2011	EP2389380A1 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use
11/30/2011	EP2389379A1 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
11/30/2011	EP2389372A1 Compositions and methods for inhibition of the jak pathway
11/30/2011	EP2389181A1 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use
11/30/2011	EP2276756B1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
11/30/2011	EP2231629B1 Modulators for amyloid beta
11/30/2011	EP2019103B1 Compound having affinity for amyloid
11/30/2011	EP1888578B1 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo [4,5-c] quinolinyl)-phenyl]propionitrile as lipid kinase inhibitor
11/30/2011	EP1633735B1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/30/2011	EP1613368B1 Carboxamide spirohydantoin cgrp receptor antagonists
11/30/2011	CN1984655B 可用于治疗血栓形成性疾病的p2y1受体脲拮抗剂 P2y1 receptors urea useful in the treatment of thrombotic diseases antagonists
11/30/2011	CN102264738A 螺吲哚满酮吡啶衍生物 Spiro indolinone derivative
11/30/2011	CN102264737A 抗病毒化合物 Antiviral compounds
11/30/2011	CN102264736A 作为TRK激酶抑制剂的取代的吡唑并[1，5-a]嘧啶化合物 As the substituted pyrazole TRK kinase inhibitors and [1,5-a] pyrimidine compounds
11/30/2011	CN102264735A 制备帕潘立酮以及它的草酸盐的一步方法 -Step process for preparing paliperidone and its oxalate
11/30/2011	CN102264731A 1,2,4-二唑衍生物及其治疗用途 1,2,4-oxadiazole derivatives and their therapeutic use
11/30/2011	CN102264369A 作为α2C肾上腺素受体激动剂的3，4-二氢-1，4-苯并噁嗪、3，4-二氢-1，4-苯并噻嗪和1，2，3，4-四氢-喹喔啉衍生物 As α2C adrenergic receptor agonists 3,4-dihydro-1,4-benzoxazine, 3,4-dihydro-1,4-benzothiazine and 1,2,3,4- Hydrogen - quinoxaline derivatives
11/30/2011	CN102260259A 四氢吡咯并吡嗪二酮并-[1-(N-乙基氨基酸)-四氢-β-咔啉]及其合成方法和应用 Tetrahydro pyrrolopyrazine dione and - [1- (N- ethyl-amino) - tetrahydro -β- carboline] and synthesis method and application
11/30/2011	CN102260258A 吡啶并[2，3-d]嘧啶衍生物，它们的制备，在治疗中的用途 Pyrido [2,3-d] pyrimidine derivatives, their preparation, use in therapy
11/30/2011	CN102260257A 吡唑并[3，4-b]吡啶衍生物及其在白光有机电致发光器件中的应用 Pyrazolo [3,4-b] pyridine derivatives and the white organic electroluminescent device of Application
11/30/2011	CN102260256A 二芳基吡唑并[3,4-b]吡啶杂环化合物及其制备方法和药物应用 Diaryl pyrazolo [3,4-b] pyridine heterocyclic compounds and their preparation and pharmaceutical applications
11/30/2011	CN101632663B 神经毒性的分子靶 Molecular targets neurotoxicity
11/30/2011	CN101367799B 苦参碱丹参酚酸b复盐和苦参素丹参酚酸b复盐及其制备方法和用途 Salvia acid b matrine and oxymatrine complex salt salvianolic acid b complex salt and its preparation method and use
11/29/2011	US8067606 Gyrase inhibitors and uses thereof
11/29/2011	US8067599 Imidazo [4,5-B] pyridine and pyrrolo [2,3-B] pyridine protein kinase inhibitors
11/29/2011	US8067598 N-methyl-2-phenyl-2-{7-[2-(4-trifluoromethyl-phenyl)-ethyl]-4,7-dihydro-5H-thieno[2,3-c]pyridin-6-yl}-acetamide; sleep disorders
11/29/2011	US8067586 Fused heteroaryl derivatives
11/29/2011	US8067435 Nitrogen-containing heterocyclic compounds, their preparation and their use as antibacterial drugs
11/29/2011	US8067434 Compounds and methods for development of Ret modulators
11/29/2011	US8067432 Liposomal, ring-opened camptothecins with prolonged, site-specific delivery of active drug to solid tumors
11/29/2011	CA2522535C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/24/2011	WO2011146401A1 Novel inhibitors of hepatitis c virus replication
11/24/2011	WO2011146358A1 Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/24/2011	WO2011146287A1 Pyrazolo[4,3-b]pyridine-7-amine inhibitors of alk5
11/24/2011	WO2011145035A1 Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
11/24/2011	WO2011145022A1 2-phenyl benzoylamides
11/24/2011	WO2011144622A1 1h - imidazo [4, 5 - c] quinolines
11/24/2011	WO2011144586A1 Bis(difluoromethyl) pyrazoles as fungicides
11/24/2011	WO2011144537A1 Photoactive composition with a high mobility of the electronic holes
11/24/2011	WO2011038097A3 Indolizine inhibitors of 5-lipoxygenase
11/24/2011	US20110288301 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
11/24/2011	US20110288293 Isoquinoline derivative
11/24/2011	US20110288116 Iap inhibitors
11/24/2011	US20110288108 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
11/24/2011	US20110288097 Pyrrolopyrazine Kinase Inhibitors
11/24/2011	US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases
11/24/2011	US20110288092 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
11/24/2011	US20110288091 Soluble mtor complexes and modulators thereof
11/24/2011	US20110288090 Inhibitors of AKT Activity
11/24/2011	US20110288085 Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
11/24/2011	US20110288078 Pyrazinopyrazines and derivatives as kinase inhibitors
11/24/2011	US20110288074 New adenosine receptor ligands and uses thereof
11/24/2011	US20110288068 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/24/2011	US20110288051 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
11/24/2011	US20110287937 Ring-fused 2-pyridone derivatives and herbicides
11/24/2011	US20110286933 Monofunctional carbocyanine dyes for in vivo and in vitro imaging
11/24/2011	CA2800161A1 Modulators of 5-ht receptors and methods of use thereof
11/24/2011	CA2799708A1 2-phenyl benzoylamides
11/23/2011	EP2388842A1 Organic electroluminescent element
11/23/2011	EP2388002A2 Antidepressant containing heterocyclic compound having specific structure
11/23/2011	EP2388001A2 Age retardant containing heterocyclic compound having specific structure
11/23/2011	EP2388000A2 Neuroprotectant containing heterocyclic compound having specific structure
11/23/2011	EP2387575A1 Alpha7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
11/23/2011	EP2387574A1 Oxadiazole beta carboline derivatives as antidiabetic compounds

1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 646